2023 National Workers' Compensation and Disability Conference

Join myMatrixx at NWCDC 2023

Join us at this year’s National Workers’ Compensation and Disability Conference (NWCDC), September 20 – 22, 2023, at the Mandalay Bay Resort in Las Vegas. NWCDC is the industry’s largest national conference, gathering thought leaders from across the country to share insights and knowledge. Make plans to stop by our booth #449.

We can't wait to see everyone in Las Vegas!

REGISTER TODAY

In-person insights from our thought leaders

myMatrixx leaders, joined by a few guest speakers, will be sharing key findings that will drive the workers' comp industry in 2023 and beyond.


How Will This Round of CDC Opioid Guidelines Impact the Industry?

Phil Wall NWCDC 2021

Phil Walls
Chief Clinical Officer
myMatrixx

WCI Dan Hunt

Dan Hunt
Corporate Medical Director
AF Group

Paul Kauffman
Director
AF Group

Aliza Krug
Clinical Director
Arbicare

Heather Sanderson
Founder and President
Sanderson Firm

Where: Session Room Three

When: September 20, 2023 | 1:00 pm – 2:00 pm

Back in 2016, the Centers for Disease Control and Prevention (CDC) issued a set of guidelines regarding the use of opioids for chronic pain. The goal of these guidelines was to decrease opioid usage and opioid related deaths by capping the maximum MED allowed, along with other guidelines for prescribing practices. In turn, the workers’ comp industry issued guidelines for opioid prescribing practices which helped to reduce overall opioid usage by 60%.

However, studies since 2016 revealed that the restrictive parameters set forth by these guidelines were leading to an increase in opioid related deaths and addiction. Due to the growing body of evidence revealing harm to patients caused by the strict parameters laid out in the 2016 CDC opioid guidelines, the CDC published new opioid guidelines in November 2022. These guidelines remove the MED cap, allowing more freedom in the prescribing practices of physicians and include a discussion for proper weaning from LT opioids.

During our moderated panel discussion, session attendees will be able to:

  • Get a brief history of opioids in the workers’ comp industry
  • Understand the breakdown of the new CDC guidelines
  • Learn how the new guidelines affect the workers’ comp industry

LEARN MORE


The Terminator or the Jetsons? How AI Could Shape the Future of Workers’ Comp

Cliff Belliveau NWCDC 2021

Cliff Belliveau
Chief Innovation Officer
myMatrixx

WCI 2022

Paul King
Chief Client Officer
myMatrixx

Bob Martin
Medical Director
Summit Consulting

Joel Raedeke
Chief Technology & Data Science Officer
Broadspire

Where: Session Room Two

When: September 20, 2023 | 1:00 pm – 2:00 pm

Our world is changing in rapid fashion: labor shortages, technology shortfalls and legislative uncertainty. How do we adapt to deliver positive outcomes for our injured worker population while containing cost? Variability has unveiled new challenges appending to decades-old opportunities. Has the time come to adopt technologies that have been embraced by other business domains? How can we use data and AI to close the innovation gap? Take this interactive journey through what is the “now” and what is “tomorrow”.

Key learnings from this session will include:

  • What AI is and what it is not in our domain?
  • How can we use AI to predict (and what are we predicting)?
  • Can machine learning lead to more effective therapy?
  • What are the enablers to predict outcomes?
  • Where does ChatGPT fit in our solution sets?
  • What data must be harvested to curate AI solutions?

LEARN MORE


Follow the Patient Journey: Sidestep Pitfalls Throughout the Life of a Claim

Don Adams

Don Adams
President
Effective Health Systems

Mike Cirillo
President
myMatrixx

Erica Fichter
Chief Operating Officer
Broadspire

Gerry Stanley
SVP & Chief Medical Officer
Harvard MedTech

Where: Session Room Two

When: September 20, 2023 | 2:30 pm – 3:30 pm

We’ve all had cases that did not go as well as we had hoped. Sometimes there are unforeseen developments. Sometimes critical information is missed at the outset that should have been considered in directing the course of care. And sometimes, seemingly for unknown reasons, the patient just doesn’t flourish. As in chess, each move in workers’ compensation is critically important and must be well thought out. In this session, you will follow this simulated patient journey (with a real patient!) through the steps of first report of injury, diagnosis, treatment plan development, use of ancillary services, functional rehabilitation, and return-to-work – or not. In the interactive discussion during this “Patient’s Progress,” examine your own knowledge and judgment of how you would make better decisions. Enjoy an enlightening, entertaining, and provocative experience that will leave you wiser and more thoughtful in how you approach your profession.

In this session, you'll be able to:

  • See what can happen at each stage of the patient's progress
  • Learn more about the decisions caregivers and claims managers make (or fail to make)
  • Understand the interaction of personalities and the often hidden impact of biopsychosocial factors

LEARN MORE


Psychedelics – Panacea or Pandora’s Box?

Phil Walls
Chief Clinical Officer
myMatrixx

Where: National Comp Theater

When: September 20, 2023 | 2:30 pm – 2:50 pm

Now that cannabis is legal in the majority of states, many health professionals are asking what’s next? The answer to that question may well be the use of psychedelic medications in the treatment of mental health conditions, and especially post-traumatic stress disorder among first responders. The majority of drugs in this category are classified as schedule 1 controlled substances, which makes their study difficult. This session will examine that evidence for and against the use of micro-doses of drugs like LSD, psilocybin and ketamine and provide insight to workers’ compensation claims professionals to evaluate their use.

At the end of this session, attendees will be able to:

  • Identify drugs that are considered to be psychedelic or hallucinogenic
  • Evaluate the use of psychedelics in terms of risk versus benefit
  • Apply knowledge from this course to determine if a prescriber has evidence to support his or her choice of therapy

LEARN MORE


SPOTLIGHT: Visit myMatrixx's Innovation Studio

Go beyond physical product sheets and make plans to interactively learn about our many solutions!

myMatrixx Innovation Studio

NWCDC conference attendees will have the opportunity to interact with data that reveals actionable insights to help our clients manage cost, patient risk and improve overall program health. Our self-guided, interactive showcase will feature data product innovations and prototypes for upcoming myMatrixx solutions that you can see first-hand on a touch-panel at our booth #449 and in the South Pacific Ballroom J near the exhibit hall, where our team members will be available to help you navigate the presentation.

Check out our innovation studio hours below:

Wednesday, September 20

  • Booth/Exhibit Hall: 10 a.m. to 4:30 p.m.
  • South Pacific Ballroom J: 8 a.m. to 5 p.m.

Thursday, September 21

  • Booth/Exhibit Hall: 9:30 a.m. to 3 p.m.
  • South Pacific Ballroom J: 8 a.m. to 3 p.m.

Navigating our presentation is simple! You’ll start on the homepage which will display key topics to discover, including:

myMatrixx Innovation Studio

Your trusted partner. Powerful, affordable pharmacy solutions for your workers’ compensation program.

Working together, working for better.